Education
About Us
Working with TipRanks
Follow Us
Daily Stock Ratings & Price Targets
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Market Cap
Any
Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
|---|---|---|---|---|---|---|---|---|---|
 Stefan Chang Aletheia CapitalNot Ranked | Broadcom | BUY $400→$500 | ― | ― | Reiterated | Broadcom (AVGO): New Buy Recommendation for This Technology Giant | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $64 | ― | 30.80% | Upgraded | ||||
 | Bicara Therapeutics Inc. | BUY $27 | ― | -16.80% | Reiterated | Buy Rating for Bicara Therapeutics Driven by Promising Efficacy and Safety of FICERA in ESMO Asia Abstract | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $172→$170 | ― | 13.90% | Upgraded | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $105 | ― | 15.90% | Upgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL $7 | ― | 1.80% | Downgraded | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $490→$550 | ― | 22.90% | Reiterated | ||||
 | Performance Shipping | BUY $4 | ― | -0.70% | Reiterated | Buy Rating on Performance Shipping: Rising Demand and Fleet Expansion Drive Potential Upside | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $535 | ― | 5.20% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $26→$11 | ― | 8.80% | Downgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $65 | ― | 18.00% | Initiated | ||||
Autodesk | BUY $385→$400 | ― | -15.00% | Reiterated | Autodesk's Promising Growth and Attractive Valuation Earns Buy Rating from Analyst | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $28→$24 | ― | 10.30% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $15→$20 | ― | 2.10% | Reiterated | ||||
| Dick's Sporting Goods | BUY $275 | ― | -10.50% | Reiterated | Analysts Are Bullish on These Consumer Cyclical Stocks: Dick's Sporting Goods (DKS), Mohawk (MHK) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $153→$152 | ― | 3.90% | Reiterated | ||||
| VICI Properties | BUY $38→$34 | ― | -2.20% | Reiterated | Goldman Sachs Sticks to Its Buy Rating for VICI Properties (VICI) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $95→$75 | ― | 6.80% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $334.81→$321.63 | ― | 7.40% | Reiterated | ||||
| nCino | BUY | ― | -7.80% | Reiterated | Positive Outlook for nCino Amid Growth Deceleration: Buy Rating Maintained | |||
| Li Auto | HOLD $25.6→$20.2 | ― | 0.00% | Reiterated | Li Auto price target lowered to $20.20 from $25.60 at Citi | |||
| Flutter Entertainment PLC | BUY $340→$320 | ― | -10.30% | Reiterated | Flutter Entertainment PLC: Buy Rating Reaffirmed Amid Alleviated Tax Risks and Growth Opportunities | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL $184→$460 | ― | 2.20% | Reiterated | ||||
| Halozyme | BUY $90 | ― | -4.50% | Reiterated | Strategic Acquisition and FDA Approval Bolster Halozyme's Market Position with a Buy Rating | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $47 | ― | 4.70% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $20 | ― | 19.70% | Reiterated | ||||
| Novo Nordisk | BUY $60→$54 | ― | -10.10% | Reiterated | Novo Nordisk price target lowered to $54 from $60 at Goldman Sachs | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $20→$18 | ― | 10.80% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $609→$612 | ― | 12.10% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $20 | ― | 8.60% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $33.5→$29 | ― | 3.90% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $23→$22 | ― | 5.90% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY | ― | 6.80% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $24.5→$23 | ― | 3.90% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $15.5→$15 | ― | 3.90% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $15→$14 | ― | 3.90% | Reiterated | ||||
 | Lear | HOLD $125 | ― | -2.40% | Reiterated | Barclays Keeps Their Hold Rating on Lear (LEA) | |||
 | Chemours Company | BUY $20→$19 | ― | -1.40% | Reiterated | Alembic Global Sticks to Their Buy Rating for Chemours Company (CC) | |||
| TRONOX | BUY $6→$5 | ― | -1.40% | Reiterated | Alembic Global Sticks to Their Buy Rating for TRONOX (TROX) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $184→$204 | ― | 13.00% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL $75→$54 | ― | 3.70% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL $9→$5 | ― | 3.70% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD | ― | 15.90% | Reiterated | ||||
| BellRing Brands | HOLD $39→$34 | ― | -5.00% | Reiterated | UBS Sticks to Its Hold Rating for BellRing Brands (BRBR) | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $25→$33 | ― | 7.00% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $16.75 | ― | 2.20% | Reiterated | ||||
| HeartBeam | BUY $8 | ― | -2.80% | Reiterated | HeartBeam's Strategic Path to Overcome Regulatory Challenges and Secure Buy Rating | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $18→$17 | ― | 0.90% | Reiterated | ||||
 | Grupo Televisa, S.A.B. | BUY $9→$10 | ― | -0.10% | Reiterated | Grupo Televisa, S.A.B. (TV) Receives a Buy from Benchmark Co. | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $430 | ― | 8.90% | Reiterated |
Rows:
